Cerebral infarction 3 weeks after intravenous immunoglobulin for Miller Fisher syndrome: a case report

INTRODUCTION: Intravenous immunoglobulin is considered generally safe and is used widely as proven, and sometimes empiric, treatment for an expanding list of autoimmune diseases. Thromboembolic complications following intravenous immunoglobulin therapy are rare and there have been only five previous...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Thashi, de Alwis, Johann Shenoj, Samarasekara, Neirosha, Rajapakse, Senaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007143/
https://www.ncbi.nlm.nih.gov/pubmed/24661403
http://dx.doi.org/10.1186/1752-1947-8-100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007143/
https://www.ncbi.nlm.nih.gov/pubmed/24661403
http://dx.doi.org/10.1186/1752-1947-8-100

Ejemplares similares